News
Hansa Biopharma AB: Hansa Biopharma announces key executive appointments to support continued growth
Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced three leadership appointments. Brian Gorman joins Hansa as Chief Legal Officer ...
StockStory.org on MSN16h
Q1 Earnings Highs And Lows: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals StocksAs the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
A truck arrives to the loading bays at the US company Pfizer manufacturing plant in Puurs, Belgium.
Ian L. Barlow and Duane C. Pozza of Wiley discuss regulatory, legal and self-regulatory action seeking to ensure that ...
Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced three leadership appointments. Brian Gorman joins Hansa as Chief Legal Officer and Corporate Secretary, effective August 4; Sandra ...
20hon MSN
A federal judge has temporarily blocked an Arkansas law that would have banned pharmacy benefit managers from owning ...
In July 2025, Bristol-Myers Squibb announced a study is to assess the safety and efficacy of nivolumab combined with ...
In July 2025, CSL Behring conducted a study in China is to investigate the pharmacokinetics (PK) of rVIII-SingleChain after ...
In an unpublished but nonetheless significant opinion, the Ninth Circuit recently affirmed the lower court’s dismissal of a consolidated lawsuit filed by SAG-AFTRA members against their union, finding ...
Open call for applications for the European media hackathon to boost innovative storytelling in media The European media hackathon Media Blend is pleased to announce that applications are now open for ...
Patent thickets hinder biosimilar access, driving up costs and delaying affordable treatments. Discover legislative solutions to enhance competition and patient care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results